Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 257,400 | 295,200 | 118,400 | 148,900 | 117,000 |
| Marketable Securities | 81,400 | 70,900 | 46,000 | 27,200 | 33,700 |
| Receivables | 91,300 | 93,600 | 94,800 | 96,500 | 89,500 |
| Inventories | 15,300 | 18,600 | 17,700 | 24,600 | 27,100 |
| Other current assets | 0 | 0 | 225,700 | 0 | 0 |
| TOTAL | $484,800 | $498,900 | $538,900 | $329,200 | $389,400 |
| Non-Current Assets | |||||
| PPE Net | 43,500 | 43,400 | 43,200 | 45,100 | 40,700 |
| Investments And Advances | 59,000 | 47,500 | 19,900 | 11,900 | 21,000 |
| Intangibles | 643,300 | 654,500 | 666,900 | 888,200 | 905,700 |
| Other Non-Current Assets | 90,100 | 91,600 | 91,400 | 62,500 | 62,000 |
| TOTAL | $835,900 | $837,000 | $821,400 | $1,007,700 | $1,029,400 |
| Total Assets | $1,320,700 | $1,335,900 | $1,360,300 | $1,336,900 | $1,418,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,600 | 15,700 | 28,500 | 20,800 | 20,500 |
| Accrued Expenses | 161,700 | 163,200 | 90,900 | 83,100 | 79,100 |
| Other current liabilities | N/A | N/A | 12,200 | N/A | N/A |
| TOTAL | $204,300 | $203,200 | $271,000 | $149,000 | $145,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | 154,000 | 224,800 |
| Deferred Revenues | N/A | 11,500 | 22,600 | 31,100 | 32,700 |
| Other Non-Current Liabilities | 112,800 | 123,500 | 128,700 | 99,500 | 95,800 |
| TOTAL | $148,600 | $164,200 | $186,900 | $312,700 | $391,900 |
| Total Liabilities | $352,900 | $367,400 | $457,900 | $461,700 | $537,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,023 | 79,855 | 78,055 | 77,052 | N/A |
| Common Shares | 800 | 800 | 800 | 800 | 800 |
| Retained earnings | -254,200 | -246,600 | -271,200 | -266,500 | -227,000 |
| Other shareholders' equity | -5,100 | -4,500 | -4,100 | -3,600 | -2,300 |
| TOTAL | $967,800 | $968,500 | $902,400 | $875,200 | $881,000 |
| Total Liabilities And Equity | $1,320,700 | $1,335,900 | $1,360,300 | $1,336,900 | $1,418,800 |